Tom's of Maine non-animal anticaries test evidence "ample," company tells FDA.
This article was originally published in The Rose Sheet
Executive Summary
TOM'S OF MAINE NON-ANIMAL ANTICARIES TEST EVIDENCE "AMPLE" to prove fluoride bioavailability, the company argued in an Aug. 26 letter to FDA. Addressing issues raised by the agency in telephone conversations regarding Tom's February petition proposing alternate test methods, the letter asserts that "FDA has ample evidence from which to conclude that the results of Tom's intraoral test provide equivalent assurance of fluoride bioavailability in lieu of animal caries testing." The Washington, D.C.-based law firm Buc and Beardsley drafted the letter for Tom's of Maine.